INS and type 1 diabetes mellitus: These systems represent the most recent available automatism in the treatment of T1D and, in a semi-automatic way, can independently regulate insulin delivery based on dynamic data from a glucose sensor; they are the Medtronic 780G system (Minimed Medtronic, Northridge, CA) and the Tandem Control IQ system (Tandem Inc., San Diego, CA).